Derosa, Giuseppe <br/><br/>
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients.  [electronic resource] 

 -  European journal of pharmacology  Sep 2011 
 - 251-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2011.05.051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--metabolism<br/>Blood Glucose--metabolism<br/>Body Mass Index<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Type 2--complications<br/>Exenatide<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Inflammation--metabolism<br/>Insulin Resistance<br/>Male<br/>Metformin--pharmacology<br/>Middle Aged<br/>Peptides--pharmacology<br/>Sulfonylurea Compounds--pharmacology<br/>Venoms--pharmacology